Clinical Trial Supplies Market - Global Industry Analysis

Clinical Trial Supplies Market By Services (Logistics & Distribution, Storage & retention, Packaging, labeling, and blinding, Manufacturing, Comparator sourcing, and Other services (solutions, ancillary supply)). By Phase (Phase 1, Phase 2, Phase 3, Phase 4, and BA/ BE studies). By Type (Small molecules, Biologic drugs, and Medical devices). By Therapeutic Area(Oncology, CNS and mental disorders, Cardiovascular diseases, Digestive disorders, Infectious diseases, Metabolic disorders, Immunology, Blood disorders, and Other therapeutic areas (respiratory disorders, dermatological disorders, rare diseases, ENT diseases, Nephrology)). By End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs), and Medical Devices Companies). and By Region – Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022-2028

Published Date: 03-May-2022 Category: Pharmaceutical Report Format : PDF Pages: 166 Report Code: ZMR-1780 Status : Published

The Clinical Trial Supplies Market was worth around USD 1,873.2 million in 2021 and is estimated to grow to about USD 3,022.4 million by 2028, with a compound annual growth rate (CAGR) of approximately 8.3 percent over the forecast period.

Description

Industry Prospective:

The Clinical Trial Supplies Market was worth around USD 1,873.2 million in 2021 and is estimated to grow to about USD 3,022.4 million by 2028, with a compound annual growth rate (CAGR) of approximately 8.3 percent over the forecast period. The report analyzes the Clinical Trial Supplies Market drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the Clinical Trial Supplies Market.

Clinical Trial Supplies Market: Overview

Clinical trial supplies cover a wide range of tools and equipment used in scientific tests, investigations, and clinical research. The increasing R&D spending in pharmaceutical and biopharmaceutical firms, as well as the expanding number of clinical trials done internationally, are driving market expansion. One of the primary factors driving the market's growth is significant growth in the biopharmaceutical industry. Clinical trials are gaining a lot of traction in the fight against diseases like HIV and cancer, as well as the creation of new medication delivery methods. Additionally, the growing tendency of contract research organizations (CROs) is favorably boosting the market growth. Furthermore, technological advancements that aid in the development of cold chain logistics and monitoring technologies are important growth drivers. Pharmaceutical, biotechnological, and medical instrument producers can outsource research efforts to CROs on a contractual basis, allowing them to use more trial materials. Moreover, extensive research and development (R&D) by both governmental and non-governmental organizations (NGOs) for the development of new pharmaceuticals and treatment procedures is predicted to boost the market's prospects.

Covid-19 Impact

The pandemic of Covid-19 has had a beneficial impact on the market's growth. Not only are vaccinations being tested in clinical trials, but also drugs to treat COVID-19 and its symptoms. This will be a significant driver in the clinical trial business. Due to the COVID-19 issue, the clinical trial supply business has seen rapid expansion. The quest for a coronavirus vaccine has sparked a surge in clinical trials around the world. Millions of people must be vaccinated over the world, but first, trials must be completed. As a result of this predicament, clinical trial supply trends have improved.

COVID-19 has pushed the introduction of new models to the market in order to ease the crisis and keep up with shifting trends. Virtual trials, which have been an underpinning technology, are gradually gaining traction and are projected to see significant expansion in the future years. As a result, virtual trials are gradually being embraced to prevent such circumstances, allowing for the deployment of innovative ways to trials and ensuring a better patient experience.

Global Clinical Trial Supplies Market

Clinical Trial Supplies Market: Driver

Pharmaceutical and biopharmaceutical businesses are increasing their R&D spending.

The pharmaceutical and biopharmaceutical industries are among the world's largest R&D spenders. Pharmaceutical and biopharmaceutical companies have increased their R&D spending significantly in the recent decade. The number of clinical trials conducted throughout the world is expected to rise as a result of this. Market players are actively seeking to assist in R&D initiatives. Increased R&D investment in the next years will significantly boost drug research and development activities, boosting demand for clinical trial supplies.

Clinical Trial Supplies Market: Restraint

Drug development is expensive.

Due to the high attrition rate of drug candidates in development, drug research and development have substantial expenses. Drug R&D processes can fail because R&D for some rare diseases is difficult and requires a specific group of people to undertake a clinical trial. Only 7 out of 100 cancer treatments that make it to the clinical testing stage are approved by the FDA; the majority of drugs fail long before they reach this stage. Developing a new treatment takes 10–15 years and costs USD 2.6 billion on average, from drug discovery to FDA approval. The FDA approves just about 12% of candidates who progress to Phase I clinical trials. This is a major stumbling block to the industry's expansion.

Clinical Trial Supplies Market: Opportunity

R&D investments provide considerable market prospects.

In terms of trial expenses and patient pools, North America and Europe, which have traditionally been the key hubs for clinical trials, are confronting challenges. Recent health changes in the United States, the patent expiration of blockbuster drugs, and the global economic slump have all had an influence on pharmaceutical company profits. As a result, a number of pharmaceutical companies are looking for chances in emerging APAC markets like India, Singapore, South Korea, and China, which offer advantages including cheaper prices and easier access to a diversified patient population. Collaborations or expansions between firms in this sector suggest that they are going towards emerging markets to assist their clients in minimizing the overall time spent in clinical trials, hence lowering their overall cost and allowing for a faster launch of products on the market (post regulatory clearance). CROs can take advantage of these opportunities by assisting pharmaceutical companies in meeting their clinical trial supply demands.

Clinical Trial Supplies Market: Segmentation

The Clinical Trial Supplies Market is segregated based on Services, phase, type, therapeutic area, and end-user.

By Services, the market is classified into Logistics & Distribution, Storage & retention, Packaging, labeling, and blinding, Manufacturing, Comparator sourcing, and Other services (solutions, ancillary supply). The supply chain management sector dominated the market, accounting for the largest share of the market's revenue. Life science firms and contract research organizations (CROs) are likely to increase their demand for supply chain management systems as clinical trials become more global and the number of clinical sites grows. Mobile and supply chain management technology use is likely to be the segment's driving force.

By Phase, the market is classified into Phase 1, Phase 2, Phase 3, Phase 4, and BA/ BE studies. During the projection period, phase III clinical trials are expected to dominate the market. Clinical studies in Phase III are more complicated than those in the previous rounds. Despite the fact that the number of medications in this phase is relatively limited, the level of complexity associated with it is the largest. This phase has the highest failure rate because the sample size and study design necessitate sophisticated dosing at an optimal level. Human and financial losses are associated with failures, and the majority of failures are caused by non-compliance with safety and efficacy requirements. Such a scenario is likely to increase demand for efficient supply chains and logistics, which would have a favorable impact on market growth.

By therapeutic area, the market is classified into Oncology, CNS and mental disorders, Cardiovascular diseases, Digestive disorders, Infectious diseases, Metabolic disorders, Immunology, Blood disorders, and Other therapeutic areas (respiratory disorders, dermatological disorders, rare diseases, ENT diseases, Nephrology). Due to the huge and growing number of research studies on cancer treatments and the growing number of firms working on bringing novel cancer medications to market, oncology is the largest segment in this market. Due to the high incidence and prevalence of cancer, healthcare systems all over the world are working on lowering the disease's burden by implementing novel diagnostic and therapeutic procedures. Effective medications could see widespread adoption in large markets including the United States, Europe, and the Asia Pacific in this scenario. Many pharmaceutical companies are investing heavily in the development of novel cancer treatments in light of these factors.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Recent Developments

  • In 2021, PPD, Inc. is now owned by Thermo Fisher Scientific. With the addition of PPD, Thermo Fisher will be able to provide a full range of world-class clinical development services, from scientific discovery to analyzing safety, efficacy, and healthcare outcomes, to managing clinical trial logistics, to drug development and manufacturing.

Regional Landscape

In terms of market share and revenue, North America dominates the clinical trial supplies market, and this dominance will continue during the projected period. This is owing to the region's large number of essential companies and well-developed healthcare infrastructure. Pharmaceutical and biopharmaceutical businesses' increased spending on R&D is the primary drivers of North America's clinical trial supplies market share. The expanding number of healthcare companies conducting clinical trials in the region, supportive government laws, and the availability of cost-effective goods are all contributing to this expansion.

The Asia Pacific, on the other hand, is expected to develop at the fastest rate during the forecast period, due to a bigger patient pool, more healthcare expenditure, and increased government assistance. Furthermore, large pharmaceutical companies are outsourcing their drug development services to countries like China, Singapore, Malaysia, and India, which is fueling the region's clinical trial supplies industry. This region's quick expansion can be ascribed to rising chronic disease prevalence, lower clinical trial costs compared to the western region, and increased government initiatives to perform clinical trials. Clinical material and supply end-users are also projected to enhance their local presence in these markets due to the strict requirements for importing clinical supplies.

Competitive Landscape

Some of the main competitors dominating the Clinical Trial Supplies Market include - Thermo Fisher (US), Catalent, Inc. (US), Parexel (US), Eurofins (France) UDG Healthcare (Ireland), Piramal Pharma Solutions (India), Almac Group (UK), PCI Pharma Services (US), PRA Health Sciences (US), Biocair (UK), Eurofins (France), Marken (US), Infosys (India), Liveo Research (India), Capsugel (a Lonza Group company) (Switzerland), SIRO Clinpharm (India), KLIFO A/S (Denmark), Clinigen (UK), Ancillare (US), N-SIDE (Belgium), ADAllen (UK), Rubicon (India), Durbin (UK), Recipharm (Sweden), Seveillar (India), Myonex (India)

Clinical Trial Supplies Market is segmented as follows:

By Services

  • Logistics & distribution
  • Storage & retention
  • Packaging, labeling, and blinding
  • Manufacturing
  • Comparator sourcing
  • Other services (solutions, ancillary supply)

By Phase

  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4
  • BA/ BE studies

By Type

  • Small molecules
  • Biologic drugs
  • Medical devices

By Therapeutic Area

  • Oncology
  • CNS and mental disorders
  • Cardiovascular diseases
  • Digestive disorders
  • Infectious diseases
  • Metabolic disorders
  • Immunology
  • Blood disorders
  • Other therapeutic areas (respiratory disorders, dermatological disorders, rare diseases, ENT diseases, Nephrology)

By End-User

  • Pharmaceutical & Biotechnology companies
  • Contract Research Organisations (CROs)
  • Medical Devices Companies

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France 
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1 Report Description and Scope
    • 1.2 Research scope
    • 1.3 Research methodology
      • 1.3.1 Market Research Type
      • 1.3.2 Market research methodology
  • Chapter 2. Executive Summary
    • 2.1 Global Clinical Trial Supplies Market, (2022 - 2028) (USD Million)
    • 2.2 Global Clinical Trial Supplies Market : snapshot
  • Chapter 3. Global Clinical Trial Supplies Market - Industry Analysis
    • 3.1 Clinical Trial Supplies Market: Market Dynamics
    • 3.2 Market Drivers
      • 3.2.1 Pharmaceutical and biopharmaceutical businesses are increasing their R&D spending.
    • 3.3 Market Restraints
      • 3.3.1. Drug development is expensive.
    • 3.4 Market Opportunities
      • 3.4.1. R&D investments provide considerable market prospects.
    • 3.5 Market Challenges
    • 3.6 Porter’s Five Forces Analysis
    • 3.7 Market Attractiveness Analysis
      • 3.7.1 Market attractiveness analysis By Services
      • 3.7.2 Market attractiveness analysis By Phase
      • 3.7.3 Market attractiveness analysis By Type
      • 3.7.4 Market attractiveness analysis By Therapeutic Area
      • 3.7.5 Market attractiveness analysis By End-User
  • Chapter 4. Global Clinical Trial Supplies Market- Competitive Landscape
    • 4.1 Company market share analysis
      • 4.1.1 Global Clinical Trial Supplies Market: company market share, 2021
    • 4.2 Strategic development
      • 4.2.1 Acquisitions & mergers
      • 4.2.2 New Product launches
      • 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4 Research and development and Regional expansion
    • 4.3 Price trend analysis
  • Chapter 5. Global Clinical Trial Supplies Market - Services Analysis
    • 5.1 Global Clinical Trial Supplies Market overview: By Services
      • 5.1.1 Global Clinical Trial Supplies Market share, By Services, 2021 and 2028
    • 5.2 Logistics & distribution
      • 5.2.1 Global Clinical Trial Supplies Market by Logistics & distribution, 2022 - 2028 (USD Million)
    • 5.3 Storage & retention
      • 5.3.1 Global Clinical Trial Supplies Market by Storage & retention, 2022 - 2028 (USD Million)
    • 5.4 Packaging, labeling, and blinding
      • 5.4.1 Global Clinical Trial Supplies Market by Packaging, labeling, and blinding, 2022 - 2028 (USD Million)
    • 5.5 Manufacturing
      • 5.5.1 Global Clinical Trial Supplies Market by Manufacturing, 2022 - 2028 (USD Million)
    • 5.6 Comparator sourcing
      • 5.6.1 Global Clinical Trial Supplies Market by Comparator sourcing, 2022 - 2028 (USD Million)
    • 5.7 Other services (solutions, ancillary supply)
      • 5.7.1 Global Clinical Trial Supplies Market by Other services (solutions, ancillary supply), 2022 - 2028 (USD Million)
  • Chapter 6. Global Clinical Trial Supplies Market - Phase Analysis
    • 6.1 Global Clinical Trial Supplies Market overview: By Phase
      • 6.1.1 Global Clinical Trial Supplies Market share, By Phase, 2021 and 2028
    • 6.2 Phase 1
      • 6.2.1 Global Clinical Trial Supplies Market by Phase 1, 2022 - 2028 (USD Million)
    • 6.3 Phase 2
      • 6.3.1 Global Clinical Trial Supplies Market by Phase 2, 2022 - 2028 (USD Million)
    • 6.4 Phase 3
      • 6.4.1 Global Clinical Trial Supplies Market by Phase 3, 2022 - 2028 (USD Million)
    • 6.5 Phase 4
      • 6.5.1 Global Clinical Trial Supplies Market by Phase 4, 2022 - 2028 (USD Million)
    • 6.6 BA/ BE studies
      • 6.6.1 Global Clinical Trial Supplies Market by BA/ BE studies, 2022 - 2028 (USD Million)
  • Chapter 7. Global Clinical Trial Supplies Market - Type Analysis
    • 7.1 Global Clinical Trial Supplies Market overview: By Type
      • 7.1.1 Global Clinical Trial Supplies Market share, By Type, 2021 and 2028
    • 7.2 Small molecules
      • 7.2.1 Global Clinical Trial Supplies Market by Small molecules, 2022 - 2028 (USD Million)
    • 7.3 Biologic drugs
      • 7.3.1 Global Clinical Trial Supplies Market by Biologic drugs, 2022 - 2028 (USD Million)
    • 7.4 Medical devices
      • 7.4.1 Global Clinical Trial Supplies Market by Medical devices, 2022 - 2028 (USD Million)
  • Chapter 8. Global Clinical Trial Supplies Market - Therapeutic Area Analysis
    • 8.1 Global Clinical Trial Supplies Market overview: By Therapeutic Area
      • 8.1.1 Global Clinical Trial Supplies Market share, By Therapeutic Area, 2021 and 2028
    • 8.2 Oncology
      • 8.2.1 Global Clinical Trial Supplies Market by Oncology, 2022 - 2028 (USD Million)
    • 8.3 CNS and mental disorders
      • 8.3.1 Global Clinical Trial Supplies Market by CNS and mental disorders, 2022 - 2028 (USD Million)
    • 8.4 Cardiovascular diseases
      • 8.4.1 Global Clinical Trial Supplies Market by Cardiovascular diseases, 2022 - 2028 (USD Million)
    • 8.5 Digestive disorders
      • 8.5.1 Global Clinical Trial Supplies Market by Digestive disorders, 2022 - 2028 (USD Million)
    • 8.6 Infectious diseases
      • 8.6.1 Global Clinical Trial Supplies Market by Infectious diseases, 2022 - 2028 (USD Million)
    • 8.7 Metabolic disorders
      • 8.7.1 Global Clinical Trial Supplies Market by Metabolic disorders, 2022 - 2028 (USD Million)
    • 8.8 Immunology
      • 8.8.1 Global Clinical Trial Supplies Market by Immunology, 2022 - 2028 (USD Million)
    • 8.9 Blood disorders
      • 8.9.1 Global Clinical Trial Supplies Market by Blood disorders, 2022 - 2028 (USD Million)
    • 8.10 Other therapeutic areas (respiratory disorders, dermatological disorders, rare diseases, ENT diseases, Nephrology)
      • 8.10.1 Global Clinical Trial Supplies Market by Other therapeutic areas (respiratory disorders, dermatological disorders, rare diseases, ENT diseases, Nephrology), 2022 - 2028 (USD Million)
  • Chapter 9. Global Clinical Trial Supplies Market - End-User Analysis
    • 9.1 Global Clinical Trial Supplies Market overview: By End-User
      • 9.1.1 Global Clinical Trial Supplies Market share, By End-User, 2021 and 2028
    • 9.2 Pharmaceutical & Biotechnology companies
      • 9.2.1 Global Clinical Trial Supplies Market by Pharmaceutical & Biotechnology companies, 2022 - 2028 (USD Million)
    • 9.3 Contract Research Organisations (CROs)
      • 9.3.1 Global Clinical Trial Supplies Market by Contract Research Organisations (CROs), 2022 - 2028 (USD Million)
    • 9.4 Medical Devices Companies
      • 9.4.1 Global Clinical Trial Supplies Market by Medical Devices Companies, 2022 - 2028 (USD Million)
  • Chapter 10. Clinical Trial Supplies Market - Regional Analysis
    • 10.1 Global Clinical Trial Supplies Market Regional Overview
    • 10.2 Global Clinical Trial Supplies Market Share, by Region, 2021 & 2028 (USD Million)
    • 10.3. North America
      • 10.3.1 North America Clinical Trial Supplies Market, 2022 - 2028 (USD Million)
        • 10.3.1.1 North America Clinical Trial Supplies Market, by Country, 2022 - 2028 (USD Million)
    • 10.4 North America Clinical Trial Supplies Market, by Services, 2022 - 2028
      • 10.4.1 North America Clinical Trial Supplies Market, by Services, 2022 - 2028 (USD Million)
    • 10.5 North America Clinical Trial Supplies Market, by Phase, 2022 - 2028
      • 10.5.1 North America Clinical Trial Supplies Market, by Phase, 2022 - 2028 (USD Million)
    • 10.6 North America Clinical Trial Supplies Market, by Type, 2022 - 2028
      • 10.6.1 North America Clinical Trial Supplies Market, by Type, 2022 - 2028 (USD Million)
    • 10.7 North America Clinical Trial Supplies Market, by Therapeutic Area, 2022 - 2028
      • 10.7.1 North America Clinical Trial Supplies Market, by Therapeutic Area, 2022 - 2028 (USD Million)
    • 10.8 North America Clinical Trial Supplies Market, by End-User, 2022 - 2028
      • 10.8.1 North America Clinical Trial Supplies Market, by End-User, 2022 - 2028 (USD Million)
    • 10.4. Europe
      • 10.4.2 Europe Clinical Trial Supplies Market, 2022 - 2028 (USD Million)
        • 10.4.2.1 Europe Clinical Trial Supplies Market, by Country, 2022 - 2028 (USD Million)
    • 10.4 Europe Clinical Trial Supplies Market, by Services, 2022 - 2028
      • 10.4.1 Europe Clinical Trial Supplies Market, by Services, 2022 - 2028 (USD Million)
    • 10.5 Europe Clinical Trial Supplies Market, by Phase, 2022 - 2028
      • 10.5.1 Europe Clinical Trial Supplies Market, by Phase, 2022 - 2028 (USD Million)
    • 10.6 Europe Clinical Trial Supplies Market, by Type, 2022 - 2028
      • 10.6.1 Europe Clinical Trial Supplies Market, by Type, 2022 - 2028 (USD Million)
    • 10.7 Europe Clinical Trial Supplies Market, by Therapeutic Area, 2022 - 2028
      • 10.7.1 Europe Clinical Trial Supplies Market, by Therapeutic Area, 2022 - 2028 (USD Million)
    • 10.8 Europe Clinical Trial Supplies Market, by End-User, 2022 - 2028
      • 10.8.1 Europe Clinical Trial Supplies Market, by End-User, 2022 - 2028 (USD Million)
    • 10.5. Asia Pacific
      • 10.5.3 Asia Pacific Clinical Trial Supplies Market, 2022 - 2028 (USD Million)
        • 10.5.3.1 Asia Pacific Clinical Trial Supplies Market, by Country, 2022 - 2028 (USD Million)
    • 10.4 Asia Pacific Clinical Trial Supplies Market, by Services, 2022 - 2028
      • 10.4.1 Asia Pacific Clinical Trial Supplies Market, by Services, 2022 - 2028 (USD Million)
    • 10.5 Asia Pacific Clinical Trial Supplies Market, by Phase, 2022 - 2028
      • 10.5.1 Asia Pacific Clinical Trial Supplies Market, by Phase, 2022 - 2028 (USD Million)
    • 10.6 Asia Pacific Clinical Trial Supplies Market, by Type, 2022 - 2028
      • 10.6.1 Asia Pacific Clinical Trial Supplies Market, by Type, 2022 - 2028 (USD Million)
    • 10.7 Asia Pacific Clinical Trial Supplies Market, by Therapeutic Area, 2022 - 2028
      • 10.7.1 Asia Pacific Clinical Trial Supplies Market, by Therapeutic Area, 2022 - 2028 (USD Million)
    • 10.8 Asia Pacific Clinical Trial Supplies Market, by End-User, 2022 - 2028
      • 10.8.1 Asia Pacific Clinical Trial Supplies Market, by End-User, 2022 - 2028 (USD Million)
    • 10.6. Latin America
      • 10.6.4 Latin America Clinical Trial Supplies Market, 2022 - 2028 (USD Million)
        • 10.6.4.1 Latin America Clinical Trial Supplies Market, by Country, 2022 - 2028 (USD Million)
    • 10.4 Latin America Clinical Trial Supplies Market, by Services, 2022 - 2028
      • 10.4.1 Latin America Clinical Trial Supplies Market, by Services, 2022 - 2028 (USD Million)
    • 10.5 Latin America Clinical Trial Supplies Market, by Phase, 2022 - 2028
      • 10.5.1 Latin America Clinical Trial Supplies Market, by Phase, 2022 - 2028 (USD Million)
    • 10.6 Latin America Clinical Trial Supplies Market, by Type, 2022 - 2028
      • 10.6.1 Latin America Clinical Trial Supplies Market, by Type, 2022 - 2028 (USD Million)
    • 10.7 Latin America Clinical Trial Supplies Market, by Therapeutic Area, 2022 - 2028
      • 10.7.1 Latin America Clinical Trial Supplies Market, by Therapeutic Area, 2022 - 2028 (USD Million)
    • 10.8 Latin America Clinical Trial Supplies Market, by End-User, 2022 - 2028
      • 10.8.1 Latin America Clinical Trial Supplies Market, by End-User, 2022 - 2028 (USD Million)
    • 10.7. The Middle-East and Africa
      • 10.7.5 The Middle-East and Africa Clinical Trial Supplies Market, 2022 - 2028 (USD Million)
        • 10.7.5.1 The Middle-East and Africa Clinical Trial Supplies Market, by Country, 2022 - 2028 (USD Million)
    • 10.4 The Middle-East and Africa Clinical Trial Supplies Market, by Services, 2022 - 2028
      • 10.4.1 The Middle-East and Africa Clinical Trial Supplies Market, by Services, 2022 - 2028 (USD Million)
    • 10.5 The Middle-East and Africa Clinical Trial Supplies Market, by Phase, 2022 - 2028
      • 10.5.1 The Middle-East and Africa Clinical Trial Supplies Market, by Phase, 2022 - 2028 (USD Million)
    • 10.6 The Middle-East and Africa Clinical Trial Supplies Market, by Type, 2022 - 2028
      • 10.6.1 The Middle-East and Africa Clinical Trial Supplies Market, by Type, 2022 - 2028 (USD Million)
    • 10.7 The Middle-East and Africa Clinical Trial Supplies Market, by Therapeutic Area, 2022 - 2028
      • 10.7.1 The Middle-East and Africa Clinical Trial Supplies Market, by Therapeutic Area, 2022 - 2028 (USD Million)
    • 10.8 The Middle-East and Africa Clinical Trial Supplies Market, by End-User, 2022 - 2028
      • 10.8.1 The Middle-East and Africa Clinical Trial Supplies Market, by End-User, 2022 - 2028 (USD Million)
  • Chapter 11. Company Profiles
    • 11.1 Thermo Fisher (US)
      • 11.1.1 Overview
      • 11.1.2 Financials
      • 11.1.3 Product Portfolio
      • 11.1.4 Business Strategy
      • 11.1.5 Recent Developments
    • 11.2 Catalent Inc. (US)
      • 11.2.1 Overview
      • 11.2.2 Financials
      • 11.2.3 Product Portfolio
      • 11.2.4 Business Strategy
      • 11.2.5 Recent Developments
    • 11.3 Parexel (US)
      • 11.3.1 Overview
      • 11.3.2 Financials
      • 11.3.3 Product Portfolio
      • 11.3.4 Business Strategy
      • 11.3.5 Recent Developments
    • 11.4 Eurofins (France) UDG Healthcare (Ireland)
      • 11.4.1 Overview
      • 11.4.2 Financials
      • 11.4.3 Product Portfolio
      • 11.4.4 Business Strategy
      • 11.4.5 Recent Developments
    • 11.5 Piramal Pharma Solutions (India)
      • 11.5.1 Overview
      • 11.5.2 Financials
      • 11.5.3 Product Portfolio
      • 11.5.4 Business Strategy
      • 11.5.5 Recent Developments
    • 11.6 Almac Group (UK)
      • 11.6.1 Overview
      • 11.6.2 Financials
      • 11.6.3 Product Portfolio
      • 11.6.4 Business Strategy
      • 11.6.5 Recent Developments
    • 11.7 PCI Pharma Services (US)
      • 11.7.1 Overview
      • 11.7.2 Financials
      • 11.7.3 Product Portfolio
      • 11.7.4 Business Strategy
      • 11.7.5 Recent Developments
    • 11.8 PRA Health Sciences (US)
      • 11.8.1 Overview
      • 11.8.2 Financials
      • 11.8.3 Product Portfolio
      • 11.8.4 Business Strategy
      • 11.8.5 Recent Developments
    • 11.9 Biocair (UK)
      • 11.9.1 Overview
      • 11.9.2 Financials
      • 11.9.3 Product Portfolio
      • 11.9.4 Business Strategy
      • 11.9.5 Recent Developments
    • 11.10 Eurofins (France)
      • 11.10.1 Overview
      • 11.10.2 Financials
      • 11.10.3 Product Portfolio
      • 11.10.4 Business Strategy
      • 11.10.5 Recent Developments
    • 11.11 Marken (US)
      • 11.11.1 Overview
      • 11.11.2 Financials
      • 11.11.3 Product Portfolio
      • 11.11.4 Business Strategy
      • 11.11.5 Recent Developments
    • 11.12 Infosys (India)
      • 11.12.1 Overview
      • 11.12.2 Financials
      • 11.12.3 Product Portfolio
      • 11.12.4 Business Strategy
      • 11.12.5 Recent Developments
    • 11.13 Liveo Research (India)
      • 11.13.1 Overview
      • 11.13.2 Financials
      • 11.13.3 Product Portfolio
      • 11.13.4 Business Strategy
      • 11.13.5 Recent Developments
    • 11.14 Capsugel (a Lonza Group company) (Switzerland)
      • 11.14.1 Overview
      • 11.14.2 Financials
      • 11.14.3 Product Portfolio
      • 11.14.4 Business Strategy
      • 11.14.5 Recent Developments
    • 11.15 SIRO Clinpharm (India)
      • 11.15.1 Overview
      • 11.15.2 Financials
      • 11.15.3 Product Portfolio
      • 11.15.4 Business Strategy
      • 11.15.5 Recent Developments
    • 11.16 KLIFO A/S (Denmark)
      • 11.16.1 Overview
      • 11.16.2 Financials
      • 11.16.3 Product Portfolio
      • 11.16.4 Business Strategy
      • 11.16.5 Recent Developments
    • 11.17 Clinigen (UK)
      • 11.17.1 Overview
      • 11.17.2 Financials
      • 11.17.3 Product Portfolio
      • 11.17.4 Business Strategy
      • 11.17.5 Recent Developments
    • 11.18 Ancillare (US)
      • 11.18.1 Overview
      • 11.18.2 Financials
      • 11.18.3 Product Portfolio
      • 11.18.4 Business Strategy
      • 11.18.5 Recent Developments
    • 11.19 N-SIDE (Belgium)
      • 11.19.1 Overview
      • 11.19.2 Financials
      • 11.19.3 Product Portfolio
      • 11.19.4 Business Strategy
      • 11.19.5 Recent Developments
    • 11.20 ADAllen (UK)
      • 11.20.1 Overview
      • 11.20.2 Financials
      • 11.20.3 Product Portfolio
      • 11.20.4 Business Strategy
      • 11.20.5 Recent Developments
    • 11.21 Rubicon (India)
      • 11.21.1 Overview
      • 11.21.2 Financials
      • 11.21.3 Product Portfolio
      • 11.21.4 Business Strategy
      • 11.21.5 Recent Developments
    • 11.22 Durbin (UK)
      • 11.22.1 Overview
      • 11.22.2 Financials
      • 11.22.3 Product Portfolio
      • 11.22.4 Business Strategy
      • 11.22.5 Recent Developments
    • 11.23 Recipharm (Sweden)
      • 11.23.1 Overview
      • 11.23.2 Financials
      • 11.23.3 Product Portfolio
      • 11.23.4 Business Strategy
      • 11.23.5 Recent Developments
    • 11.24 Seveillar (India)
      • 11.24.1 Overview
      • 11.24.2 Financials
      • 11.24.3 Product Portfolio
      • 11.24.4 Business Strategy
      • 11.24.5 Recent Developments
    • 11.25 Myonex (India)
      • 11.25.1 Overview
      • 11.25.2 Financials
      • 11.25.3 Product Portfolio
      • 11.25.4 Business Strategy
      • 11.25.5 Recent Developments

Table Of Figures

  • 1. Market research Type
  • 2. Market research methodology
  • 3. Global Clinical Trial Supplies Market, 2022 - 2028 (USD Million)
  • 4. Porter’s Five Forces Analysis
  • 5. Global Clinical Trial Supplies Market attractiveness, By Services
  • 6. Global Clinical Trial Supplies Market attractiveness, By Phase
  • 7. Global Clinical Trial Supplies Market attractiveness, By Type
  • 8. Global Clinical Trial Supplies Market attractiveness, By Therapeutic Area
  • 9. Global Clinical Trial Supplies Market attractiveness, By End-User
  • 10. Global Clinical Trial Supplies Market share by Services, 2022 and 2028 (USD Million)
  • 11. Global Clinical Trial Supplies Market by Logistics & distribution, 2022 - 2028 (USD Million)
  • 12. Global Clinical Trial Supplies Market by Storage & retention, 2022 - 2028 (USD Million)
  • 13. Global Clinical Trial Supplies Market by Packaging, labeling, and blinding, 2022 - 2028 (USD Million)
  • 14. Global Clinical Trial Supplies Market by Manufacturing, 2022 - 2028 (USD Million)
  • 15. Global Clinical Trial Supplies Market by Comparator sourcing, 2022 - 2028 (USD Million)
  • 16. Global Clinical Trial Supplies Market by Other services (solutions, ancillary supply), 2022 - 2028 (USD Million)
  • 17. Global Clinical Trial Supplies Market share by Phase, 2022 and 2028 (USD Million)
  • 18. Global Clinical Trial Supplies Market by Phase 1, 2022 - 2028 (USD Million)
  • 19. Global Clinical Trial Supplies Market by Phase 2, 2022 - 2028 (USD Million)
  • 20. Global Clinical Trial Supplies Market by Phase 3, 2022 - 2028 (USD Million)
  • 21. Global Clinical Trial Supplies Market by Phase 4, 2022 - 2028 (USD Million)
  • 22. Global Clinical Trial Supplies Market by BA/ BE studies, 2022 - 2028 (USD Million)
  • 23. Global Clinical Trial Supplies Market share by Type, 2022 and 2028 (USD Million)
  • 24. Global Clinical Trial Supplies Market by Small molecules, 2022 - 2028 (USD Million)
  • 25. Global Clinical Trial Supplies Market by Biologic drugs, 2022 - 2028 (USD Million)
  • 26. Global Clinical Trial Supplies Market by Medical devices, 2022 - 2028 (USD Million)
  • 27. Global Clinical Trial Supplies Market share by Therapeutic Area, 2022 and 2028 (USD Million)
  • 28. Global Clinical Trial Supplies Market by Oncology, 2022 - 2028 (USD Million)
  • 29. Global Clinical Trial Supplies Market by CNS and mental disorders, 2022 - 2028 (USD Million)
  • 30. Global Clinical Trial Supplies Market by Cardiovascular diseases, 2022 - 2028 (USD Million)
  • 31. Global Clinical Trial Supplies Market by Digestive disorders, 2022 - 2028 (USD Million)
  • 32. Global Clinical Trial Supplies Market by Infectious diseases, 2022 - 2028 (USD Million)
  • 33. Global Clinical Trial Supplies Market by Metabolic disorders, 2022 - 2028 (USD Million)
  • 34. Global Clinical Trial Supplies Market by Immunology, 2022 - 2028 (USD Million)
  • 35. Global Clinical Trial Supplies Market by Blood disorders, 2022 - 2028 (USD Million)
  • 36. Global Clinical Trial Supplies Market by Other therapeutic areas (respiratory disorders, dermatological disorders, rare diseases, ENT diseases, Nephrology), 2022 - 2028 (USD Million)
  • 37. Global Clinical Trial Supplies Market share by End-User, 2022 and 2028 (USD Million)
  • 38. Global Clinical Trial Supplies Market by Pharmaceutical & Biotechnology companies, 2022 - 2028 (USD Million)
  • 39. Global Clinical Trial Supplies Market by Contract Research Organisations (CROs), 2022 - 2028 (USD Million)
  • 40. Global Clinical Trial Supplies Market by Medical Devices Companies, 2022 - 2028 (USD Million)
  • 41. Global Clinical Trial Supplies Market share, by Region, 2022 and 2028
  • 42. North America Clinical Trial Supplies Market, 2022 - 2028 (USD Million)
  • 43. Europe Clinical Trial Supplies Market, 2022 - 2028 (USD Million)
  • 44. Asia Pacific Clinical Trial Supplies Market, 2022 - 2028 (USD Million)
  • 45. Latin America Clinical Trial Supplies Market, 2022 - 2028 (USD Million)
  • 46. The Middle-East and Africa Clinical Trial Supplies Market, 2022 - 2028 (USD Million)

Table Of Tables

  • 1. Global Clinical Trial Supplies Market: Snapshot
  • 2. Drivers of the Clinical Trial Supplies Market: impact analysis
  • 3. North America Clinical Trial Supplies Market revenue, By Services, 2022 - 2028 (USD Million)
  • 4. North America Clinical Trial Supplies Market revenue, By Phase, 2022 - 2028 (USD Million)
  • 5. North America Clinical Trial Supplies Market revenue, By Type, 2022 - 2028 (USD Million)
  • 6. North America Clinical Trial Supplies Market revenue, By Therapeutic Area, 2022 - 2028 (USD Million)
  • 7. North America Clinical Trial Supplies Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 8. U.S. Clinical Trial Supplies Market revenue, By Services, 2022 - 2028 (USD Million)
  • 9. U.S. Clinical Trial Supplies Market revenue, By Phase, 2022 - 2028 (USD Million)
  • 10. U.S. Clinical Trial Supplies Market revenue, By Type, 2022 - 2028 (USD Million)
  • 11. U.S. Clinical Trial Supplies Market revenue, By Therapeutic Area, 2022 - 2028 (USD Million)
  • 12. U.S. Clinical Trial Supplies Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 13. Canada Clinical Trial Supplies Market revenue, By Services, 2022 - 2028 (USD Million)
  • 14. Canada Clinical Trial Supplies Market revenue, By Phase, 2022 - 2028 (USD Million)
  • 15. Canada Clinical Trial Supplies Market revenue, By Type, 2022 - 2028 (USD Million)
  • 16. Canada Clinical Trial Supplies Market revenue, By Therapeutic Area, 2022 - 2028 (USD Million)
  • 17. Canada Clinical Trial Supplies Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 18. Europe Clinical Trial Supplies Market revenue, By Services, 2022 - 2028 (USD Million)
  • 19. Europe Clinical Trial Supplies Market revenue, By Phase, 2022 - 2028 (USD Million)
  • 20. Europe Clinical Trial Supplies Market revenue, By Type, 2022 - 2028 (USD Million)
  • 21. Europe Clinical Trial Supplies Market revenue, By Therapeutic Area, 2022 - 2028 (USD Million)
  • 22. Europe Clinical Trial Supplies Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 23. Germany Clinical Trial Supplies Market revenue, By Services, 2022 - 2028 (USD Million)
  • 24. Germany Clinical Trial Supplies Market revenue, By Phase, 2022 - 2028 (USD Million)
  • 25. Germany Clinical Trial Supplies Market revenue, By Type, 2022 - 2028 (USD Million)
  • 26. Germany Clinical Trial Supplies Market revenue, By Therapeutic Area, 2022 - 2028 (USD Million)
  • 27. Germany Clinical Trial Supplies Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 28. France Clinical Trial Supplies Market revenue, By Services, 2022 - 2028 (USD Million)
  • 29. France Clinical Trial Supplies Market revenue, By Phase, 2022 - 2028 (USD Million)
  • 30. France Clinical Trial Supplies Market revenue, By Type, 2022 - 2028 (USD Million)
  • 31. France Clinical Trial Supplies Market revenue, By Therapeutic Area, 2022 - 2028 (USD Million)
  • 32. France Clinical Trial Supplies Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 33. U.K. Clinical Trial Supplies Market revenue, By Services, 2022 - 2028 (USD Million)
  • 34. U.K. Clinical Trial Supplies Market revenue, By Phase, 2022 - 2028 (USD Million)
  • 35. U.K. Clinical Trial Supplies Market revenue, By Type, 2022 - 2028 (USD Million)
  • 36. U.K. Clinical Trial Supplies Market revenue, By Therapeutic Area, 2022 - 2028 (USD Million)
  • 37. U.K. Clinical Trial Supplies Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 38. Italy Clinical Trial Supplies Market revenue, By Services, 2022 - 2028 (USD Million)
  • 39. Italy Clinical Trial Supplies Market revenue, By Phase, 2022 - 2028 (USD Million)
  • 40. Italy Clinical Trial Supplies Market revenue, By Type, 2022 - 2028 (USD Million)
  • 41. Italy Clinical Trial Supplies Market revenue, By Therapeutic Area, 2022 - 2028 (USD Million)
  • 42. Italy Clinical Trial Supplies Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 43. Spain Clinical Trial Supplies Market revenue, By Services, 2022 - 2028 (USD Million)
  • 44. Spain Clinical Trial Supplies Market revenue, By Phase, 2022 - 2028 (USD Million)
  • 45. Spain Clinical Trial Supplies Market revenue, By Type, 2022 - 2028 (USD Million)
  • 46. Spain Clinical Trial Supplies Market revenue, By Therapeutic Area, 2022 - 2028 (USD Million)
  • 47. Spain Clinical Trial Supplies Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 48. Rest of Europe Clinical Trial Supplies Market revenue, By Services, 2022 - 2028 (USD Million)
  • 49. Rest of Europe Clinical Trial Supplies Market revenue, By Phase, 2022 - 2028 (USD Million)
  • 50. Rest of Europe Clinical Trial Supplies Market revenue, By Type, 2022 - 2028 (USD Million)
  • 51. Rest of Europe Clinical Trial Supplies Market revenue, By Therapeutic Area, 2022 - 2028 (USD Million)
  • 52. Rest of Europe Clinical Trial Supplies Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 53. Asia Pacific Clinical Trial Supplies Market revenue, By Services, 2022 - 2028 (USD Million)
  • 54. Asia Pacific Clinical Trial Supplies Market revenue, By Phase, 2022 - 2028 (USD Million)
  • 55. Asia Pacific Clinical Trial Supplies Market revenue, By Type, 2022 - 2028 (USD Million)
  • 56. Asia Pacific Clinical Trial Supplies Market revenue, By Therapeutic Area, 2022 - 2028 (USD Million)
  • 57. Asia Pacific Clinical Trial Supplies Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 58. China Clinical Trial Supplies Market revenue, By Services, 2022 - 2028 (USD Million)
  • 59. China Clinical Trial Supplies Market revenue, By Phase, 2022 - 2028 (USD Million)
  • 60. China Clinical Trial Supplies Market revenue, By Type, 2022 - 2028 (USD Million)
  • 61. China Clinical Trial Supplies Market revenue, By Therapeutic Area, 2022 - 2028 (USD Million)
  • 62. China Clinical Trial Supplies Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 63. Japan Clinical Trial Supplies Market revenue, By Services, 2022 - 2028 (USD Million)
  • 64. Japan Clinical Trial Supplies Market revenue, By Phase, 2022 - 2028 (USD Million)
  • 65. Japan Clinical Trial Supplies Market revenue, By Type, 2022 - 2028 (USD Million)
  • 66. Japan Clinical Trial Supplies Market revenue, By Therapeutic Area, 2022 - 2028 (USD Million)
  • 67. Japan Clinical Trial Supplies Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 68. India Clinical Trial Supplies Market revenue, By Services, 2022 - 2028 (USD Million)
  • 69. India Clinical Trial Supplies Market revenue, By Phase, 2022 - 2028 (USD Million)
  • 70. India Clinical Trial Supplies Market revenue, By Type, 2022 - 2028 (USD Million)
  • 71. India Clinical Trial Supplies Market revenue, By Therapeutic Area, 2022 - 2028 (USD Million)
  • 72. India Clinical Trial Supplies Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 73. South Korea Clinical Trial Supplies Market revenue, By Services, 2022 - 2028 (USD Million)
  • 74. South Korea Clinical Trial Supplies Market revenue, By Phase, 2022 - 2028 (USD Million)
  • 75. South Korea Clinical Trial Supplies Market revenue, By Type, 2022 - 2028 (USD Million)
  • 76. South Korea Clinical Trial Supplies Market revenue, By Therapeutic Area, 2022 - 2028 (USD Million)
  • 77. South Korea Clinical Trial Supplies Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 78. South-East Asia Clinical Trial Supplies Market revenue, By Services, 2022 - 2028 (USD Million)
  • 79. South-East Asia Clinical Trial Supplies Market revenue, By Phase, 2022 - 2028 (USD Million)
  • 80. South-East Asia Clinical Trial Supplies Market revenue, By Type, 2022 - 2028 (USD Million)
  • 81. South-East Asia Clinical Trial Supplies Market revenue, By Therapeutic Area, 2022 - 2028 (USD Million)
  • 82. South-East Asia Clinical Trial Supplies Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 83. Rest of Asia Pacific Clinical Trial Supplies Market revenue, By Services, 2022 - 2028 (USD Million)
  • 84. Rest of Asia Pacific Clinical Trial Supplies Market revenue, By Phase, 2022 - 2028 (USD Million)
  • 85. Rest of Asia Pacific Clinical Trial Supplies Market revenue, By Type, 2022 - 2028 (USD Million)
  • 86. Rest of Asia Pacific Clinical Trial Supplies Market revenue, By Therapeutic Area, 2022 - 2028 (USD Million)
  • 87. Rest of Asia Pacific Clinical Trial Supplies Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 88. Latin America Clinical Trial Supplies Market revenue, By Services, 2022 - 2028 (USD Million)
  • 89. Latin America Clinical Trial Supplies Market revenue, By Phase, 2022 - 2028 (USD Million)
  • 90. Latin America Clinical Trial Supplies Market revenue, By Type, 2022 - 2028 (USD Million)
  • 91. Latin America Clinical Trial Supplies Market revenue, By Therapeutic Area, 2022 - 2028 (USD Million)
  • 92. Latin America Clinical Trial Supplies Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 93. Brazil Clinical Trial Supplies Market revenue, By Services, 2022 - 2028 (USD Million)
  • 94. Brazil Clinical Trial Supplies Market revenue, By Phase, 2022 - 2028 (USD Million)
  • 95. Brazil Clinical Trial Supplies Market revenue, By Type, 2022 - 2028 (USD Million)
  • 96. Brazil Clinical Trial Supplies Market revenue, By Therapeutic Area, 2022 - 2028 (USD Million)
  • 97. Brazil Clinical Trial Supplies Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 98. Mexico Clinical Trial Supplies Market revenue, By Services, 2022 - 2028 (USD Million)
  • 99. Mexico Clinical Trial Supplies Market revenue, By Phase, 2022 - 2028 (USD Million)
  • 100. Mexico Clinical Trial Supplies Market revenue, By Type, 2022 - 2028 (USD Million)
  • 101. Mexico Clinical Trial Supplies Market revenue, By Therapeutic Area, 2022 - 2028 (USD Million)
  • 102. Mexico Clinical Trial Supplies Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 103. Rest of Latin America Clinical Trial Supplies Market revenue, By Services, 2022 - 2028 (USD Million)
  • 104. Rest of Latin America Clinical Trial Supplies Market revenue, By Phase, 2022 - 2028 (USD Million)
  • 105. Rest of Latin America Clinical Trial Supplies Market revenue, By Type, 2022 - 2028 (USD Million)
  • 106. Rest of Latin America Clinical Trial Supplies Market revenue, By Therapeutic Area, 2022 - 2028 (USD Million)
  • 107. Rest of Latin America Clinical Trial Supplies Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 108. The Middle-East and Africa Clinical Trial Supplies Market revenue, By Services, 2022 - 2028 (USD Million)
  • 109. The Middle-East and Africa Clinical Trial Supplies Market revenue, By Phase, 2022 - 2028 (USD Million)
  • 110. The Middle-East and Africa Clinical Trial Supplies Market revenue, By Type, 2022 - 2028 (USD Million)
  • 111. The Middle-East and Africa Clinical Trial Supplies Market revenue, By Therapeutic Area, 2022 - 2028 (USD Million)
  • 112. The Middle-East and Africa Clinical Trial Supplies Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 113. GCC Countries Clinical Trial Supplies Market revenue, By Services, 2022 - 2028 (USD Million)
  • 114. GCC Countries Clinical Trial Supplies Market revenue, By Phase, 2022 - 2028 (USD Million)
  • 115. GCC Countries Clinical Trial Supplies Market revenue, By Type, 2022 - 2028 (USD Million)
  • 116. GCC Countries Clinical Trial Supplies Market revenue, By Therapeutic Area, 2022 - 2028 (USD Million)
  • 117. GCC Countries Clinical Trial Supplies Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 118. South Africa Clinical Trial Supplies Market revenue, By Services, 2022 - 2028 (USD Million)
  • 119. South Africa Clinical Trial Supplies Market revenue, By Phase, 2022 - 2028 (USD Million)
  • 120. South Africa Clinical Trial Supplies Market revenue, By Type, 2022 - 2028 (USD Million)
  • 121. South Africa Clinical Trial Supplies Market revenue, By Therapeutic Area, 2022 - 2028 (USD Million)
  • 122. South Africa Clinical Trial Supplies Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 123. Rest of Middle-East Africa Clinical Trial Supplies Market revenue, By Services, 2022 - 2028 (USD Million)
  • 124. Rest of Middle-East Africa Clinical Trial Supplies Market revenue, By Phase, 2022 - 2028 (USD Million)
  • 125. Rest of Middle-East Africa Clinical Trial Supplies Market revenue, By Type, 2022 - 2028 (USD Million)
  • 126. Rest of Middle-East Africa Clinical Trial Supplies Market revenue, By Therapeutic Area, 2022 - 2028 (USD Million)
  • 127. Rest of Middle-East Africa Clinical Trial Supplies Market revenue, By End-User, 2022 - 2028 (USD Million)

Methodology

Free Analysis

A clinical trial is a complex activity which requires management of several processes and functions. The primary aim of a pharmaceutical manufacturer in any of the clinical studies is to optimize the clinical trial supplies so that materials packed for the investigational purpose is distributed to the patients enrolled in the clinical trials on time. The activities included in the clinical trial supplies are clinical packaging, project management, labeling, randomization generation, blinding, supply chain logistics, return drug accountability, distribution, destruction, etc. Due to the escalating costs involved in the discovery and development of new drugs, the clinical trial supplies is gaining traction in the market.

The market for clinical trials supplies is witnessing strong growth rate due to the rising prevalence of chronic diseases such as HIV, cancer, and epilepsy; increased importance on determining the toxicity level of drug discovery in its early stage of development; and the increasing demand for outsourcing the drug discovery services to the other countries. Growing number of life sciences-related researches carried out in various countries and rising government funding in the discovery and development of new drugs the market for clinical trial supplies is expected to witness rapid growth in the forecast period. Even the new entrants entering the clinical trial supplies market are focusing on the launch of new products and technologies. But, the lack of trained professionals and infrastructure facilities is anticipated to hamper the market growth.

Global Clinical Trial Supplies Market

The market for clinical trial supplies market is segmented based on product/service type, application type, phase, and end user. Based on product/service type, the market is segmented into packaging & labeling, manufacturing, and storage and distribution. Based on applications, the clinical trial supplies market is segmented into oncology, CNS, cardiovascular, infectious diseases, metabolic disorders, and others. Based on the phase, the market is categorized into phase I, phase II, phase III, and others. The end-user segment is divided into contract research organizations, pharmaceutical and biotechnology companies, research institutes, & others.

North America holds the largest share in the market for clinical trial supplies owing to the increasing number of R&D activities in the field of drug discovery, the presence of a large number of multinational pharma and biotech companies which carry out clinical trials, and the availability of advanced and well-developed healthcare infrastructure. Europe holds the second largest share in the market due to rising government funding and high healthcare investment. The Asia Pacific is witnessing significant growth rate due to the unmet health care needs and increased government funding towards research activities. Also, most of the pharma companies are outsourcing their drug development services to various developing countries such as Malaysia, China, India, and Singapore which is further propelling the growth of clinical trial supplies market. 

Some of the leading players in clinical trial supplies market include KLIFO A/S, Patheon, Inc., Almac Group Ltd., PAREXEL International Corporation, PCI Services, Sharp Packaging Services, Biocair, Movianto, Thermo Fisher Scientific, Inc. Catalent Pharma Solutions, Inc., and others.

Choose License Type

FrequentlyAsked Questions

The increasing R&D spending in pharmaceutical and biopharmaceutical firms, as well as the expanding number of clinical trials done internationally, are driving market expansion. One of the primary factors driving the market's growth is significant growth in the biopharmaceutical industry. Clinical trials are gaining a lot of traction in the fight against diseases like HIV and cancer, as well as the creation of new medication delivery methods.

According to the Market Research report, the Clinical Trial Supplies Market was worth about 1,873.2 (USD million) in 2021 and is predicted to grow to around 3,022.4 (USD million) by 2028, with a compound annual growth rate (CAGR) of around 8.3 percent.

 

In terms of market share and revenue, North America dominates the clinical trial supplies market, and this dominance will continue during the projected period. This is owing to the region's large number of essential companies and well-developed healthcare infrastructure. Pharmaceutical and biopharmaceutical businesses' increased spending on R&D is the primary drivers of North America's clinical trial supplies market share.

 

Some of the main competitors dominating the Clinical Trial Supplies Market include - Thermo Fisher (US), Catalent, Inc. (US), Parexel (US), Eurofins (France) UDG Healthcare (Ireland), Piramal Pharma Solutions (India), Almac Group (UK), PCI Pharma Services (US), PRA Health Sciences (US), Biocair (UK), Eurofins (France), Marken (US), Infosys (India), Liveo Research (India), Capsugel (a Lonza Group company) (Switzerland), SIRO Clinpharm (India), KLIFO A/S (Denmark), Clinigen (UK), Ancillare (US), N-SIDE (Belgium), ADAllen (UK), Rubicon (India), Durbin (UK), Recipharm (Sweden), Seveillar (India), Myonex (India)

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • paypal
  • amazon
  • visa
  • master card

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed